Delivery Order SPE2DB20D2014-SPE2DB25FB43P

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $3,261.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialized medication, and has an ultimate completion date of March 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award is a Delivery Order valued at $1,694.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $1,278.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, with a completion date of March 26, 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.94, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $4,304.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The award is a delivery order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the...
This federal contract award, valued at $1,022.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order (SPE2DB24FRJF0) issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, at a ceiling value of $1,068.84. The contract has a firm fixed price pricing type and an ultimate completion date of May 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB43P
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract is a Delivery Order valued at $3,807.40 with a firm fixed price and an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 12:52 AM